2019 Scripps MD Anderson's Oncology Update

 

Hematologic Oncology
16:21

2019 Scripps MD Anderson's Oncology Update

CLL Practice Changing Studies From ASCO 2019: Acalabrutinib + Obinutuzumab in R/R, Superiority of Venetoclax/obinutuzumab in Elderly Patients & Comparing Frontline Options

FEATURING Alan Saven
  • 508 views
  • August 19, 2019
22:43

2019 Scripps MD Anderson's Oncology Update

Myeloma Practice Changing Studies From ASCO 2019: High-Risk Smoldering Myeloma Early Intervention & D-VTd for Newly Diagnosed Who Are Eligible for ASCT

FEATURING Alan Saven
  • 529 views
  • August 19, 2019
12:47

2019 Scripps MD Anderson's Oncology Update

Lymphoma Practicing Changing ASCO19 Studies: Novel Agents Prior to R-Chop for Newly Diagnosed DLBCL & Concurrent vs Delayed Rituximab in Hairy Cell Lymphoma

FEATURING Alan Saven
  • 717 views
  • August 19, 2019
  • 3